瑞科生物-B：魏其芳、王静获委任为执行董事

Core Viewpoint - The company has proposed to abolish the supervisory board, which has been approved in a temporary shareholders' meeting, effective from December 19, 2025 [1] Group 1 - The supervisory board will be dissolved, and the company's audit committee will assume the supervisory functions as per legal and regulatory requirements [1] - Current members of the supervisory board will no longer serve in that capacity [1] Group 2 - Mr. Xu Haoyu has been appointed as a non-executive director [1] - Mr. Wei Qifang has been appointed as an executive director [1] - Ms. Wang Jing has also been appointed as an executive director [1]